KALA BIO, Inc. (LON:0JQ2)
7.20
-0.82 (-10.27%)
At close: Feb 19, 2025
KALA BIO Employees
KALA BIO had 43 employees as of December 31, 2023. The number of employees increased by 9 or 26.47% compared to the previous year.
Employees
43
Change (1Y)
9
Growth (1Y)
26.47%
Revenue / Employee
n/a
Profits / Employee
-676.05K GBP
Market Cap
31.99M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
Hikma Pharmaceuticals | 9,100 |
ConvaTec Group | 10,136 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |
KALA BIO News
- 11 days ago - KALA BIO Announces Chief Executive Officer Transition - GlobeNewsWire
- 7 weeks ago - KALA BIO Announces $10,750,000 Private Placement - GlobeNewsWire
- 3 months ago - KALA BIO to Present at Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 9 months ago - KALA BIO to Present at Jefferies Global Healthcare Conference - GlobeNewsWire
- 10 months ago - KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 11 months ago - KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 1 year ago - KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference - GlobeNewsWire
- 1 year ago - KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire